Ritesh Intl. (519097)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• High capital efficiency: ROE of 23.58% and ROCE of 17.76% are strong for a commodity chemical business.
• Reasonable valuation: P/E of 11.06 and P/B of 1.23 versus book value of ₹22.09 offer a margin of safety if earnings hold.
• Solid growth metrics: Sales growth of 13.88% and profit growth of 29.70% with a PEG of 0.51 suggest cheapness relative to growth.
• Piotroski F-Score of 7/9 indicates generally sound financial health across the metrics available.
• Price is near the lower end of the 52-week range, reducing the entry point compared with the ₹78.69 high.

Concerns

• Commodity chemicals are inherently cyclical and often lack pricing power or a durable moat.
• Latest quarter net profit is only ₹1 Cr on sales of ₹44 Cr, showing a thin margin that could disappear in a downturn.
• Tiny market cap of ₹24 Cr creates liquidity, governance, and business risk; it is not a large, stable compounder.
• No dividend, no promoter holding data, and no debt/equity disclosure leave important questions unanswered.

AI Analysis

At ₹27.26, Ritesh Intl. presents an intriguing but risky value case. The numbers I see would make Graham pause and smile: a P/E of 11.06, a P/B of 1.23 against book value of ₹22.09, and a return on equity of 23.58%. The company has grown sales by 13.88% and profits by 29.70%, giving a PEG of 0.51—cheap if the growth is durable. A Piotroski score of 7/9 adds some comfort. However, I must remind myself: this is a commodity chemical business. In my world, commodity businesses lack a moat. They cannot raise prices when costs rise; they are at the mercy of capacity cycles and global supply. The latest quarter shows sales of ₹44 Cr but net profit of only ₹1 Cr—a very thin margin. That tells me the underlying economics can erode quickly when industry conditions turn. Also, with a market cap of just ₹24 Cr, this is a micro-cap; I must demand a wider margin of safety and question liquidity. No dividend, no promoter holding data, and no debt-equity ratio disclosed—these are gaps, not a verdict. If I look at this purely as a statistical bargain, the price is near the 52-week low of ₹25.27, and it trades far below its high of ₹78.69. That fall itself is a warning: Mr. Market has repriced the business's cyclical prospects. I would only consider a small position, and only after checking the balance sheet and management actions. I need to see consistent cash flow, not just accounting profit. Valuation is attractive only if the commodity upcycle holds; if not, the low P/E may be a value trap. This is a possible cyclical buy, not a wonderful business at a fair price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer